BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Appl...

November 27, 2023 | News

Boehringer Ingelheim broadens immuno-oncology portfolio with T3 Pharma acquisition

Despite the significant transformation of the cancer treatment landscape by immunotherapies, long-term remissions only occur in 15-20% of cancer patients. ...

November 27, 2023 | News

Simcere and Connect ink exclusive deal for autoimmune drug Rademikibart.

Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...

November 24, 2023 | News

BeiGene and Ensem Therapeutics Partner to Advance CDK2 Inhibitor

“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...

November 23, 2023 | News

Ark Biopharma's AK0610 Receives NMPA IND Approval for RSV Neutralizing Antibody

It is anticipated to protect infants throughout an entire RSV season. ArkBio licensed the drug's intellectual properties from the Institute of Microb...

November 23, 2023 | News

Porton Advanced and Ascle Therapeutics Form Strategic Partnership for NK Cell Applications in Cancer Prevention, Beauty, and Anti-aging

Porton Advanced is committed to providing end-to-end gene and cell therapy CDMO services, covering fields such as plasmids, cell therapy, gene therapy, and...

November 21, 2023 | News

CU Medicine Innovates MOZAICTM Microbiome Tech for Fecal Microbiota Transplants

Clostridioides difficile infection (CDI) is a common hospital-acquired infection worldwide. Recurrence and mortality rates have been reported to be up...

November 17, 2023 | News

Kite Expands Collaboration with Arcellx, Exercises Option for ACLX-001 in Multiple Myeloma

-- The companies expand the scope of their existing collaboration for CART-ddBCMA to include lymphomas -- -- Kite exercises option to Arcellx’s ARC-...

November 16, 2023 | News

Foundation Medicine Collaborates with Pierre Fabre on Non-Small Cell Lung Cancer Diagnostics

The companies will work collaboratively to seek the regulatory approval for Foundation Medicine assays which detect mutations including BRAFV600E to i...

November 16, 2023 | News

South Korean Firm Lunit Raises $150 Million in Capital Boost

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the successful completion ...

November 16, 2023 | News

Guardant Health Introduces Shield Blood Test for Colorectal Cancer in South Korea

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and the third-leading cause of cancer-related deaths in South Korea.1,2 Gua...

November 13, 2023 | News

PharmAbcine Advances PMC-403 Clinical Trial in South Korea for Macular Degeneration

Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment. The starting dose (0.7m...

November 10, 2023 | News

Antech Launches Comprehensive Veterinary Diagnostics in the UK with State-of-the-Art Lab

Antech, the full-service veterinary diagnostics business that is part of the Science & Diagnostics division of Mars Petcare, announced the openin...

November 08, 2023 | News

Lerna Bio unveils its first-in-class solution to combat liver failure

During this esteemed event, Lerna Bio will present two highly anticipated presentations: "Promoting Liver Regeneration and Protection with LR1: A Novel siR...

November 07, 2023 | News

Stay Connected